Changes in DCX expression across inflammatory subgroups reached a trend level of statistical significance, with planned contrasts showing reduced expression in high compared to low inflammation schizophrenia [30%, ANCOVA (RIN), F(4,78) = 2.01, p = 0.10, post hocp = 0.02] and low inflammation controls (32%, post hoc p = 0.01, Fig. 5E). This evidence concerns the gene DCX and schizophrenia.